Drug Database
Back to search

Finland· FI-REL-REL1566

Abboticin

A erythromycin product containing erythromycin ethylsuccinate, registered in Finland by Abbott Scandinavia AB. The same ATC class is registered in 13 of our 19 countries.

ATC J01FA01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedAbboticinATCJ01FA01REGISTER NO.FI-REL-REL1566PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about erythromycin ethylsuccinateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Erythromycin is registered in 13 of 19 countries.

Countries holding a registration under ATC J01FA01 (erythromycin), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 6 of them publish a price we can compare per daily dose
Search erythromycin products by name

Erythromycin · ATC J01FA01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Erythromycin ethylsuccinate
Manufacturer
Abbott Scandinavia AB
Country
Finland (FI)
ATC code
J01FA01
ATC class
Erythromycin
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1011 interactions on record for erythromycin.

Graded by severity as the source publishes them — 216 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check erythromycin against other medicinesHow interaction checks work

Erythromycin · interactions on record

1011 records

  • 216 severe
  • 424 moderate
  • 70 minor
  • 227 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • NaloxegolA06AH03severe

74 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Erythromycin in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All erythromycin products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Belgium · Erythroforte
  • Germany · Erythrocin Neo
  • Denmark · Abboticin, Abboticin Novum
  • Spain · Eritromicina Normon, Pantomicina
  • France · Ery Enfants, Erythrocine
  • United Kingdom (Northern Ireland) · Erythromycin, Erythromycin Amdipharm Uk
  • Ireland · Erythroped, Erythroped Pi
  • Luxembourg · Erythrocine, Erythroforte
  • Malta · Primacine
  • Norway · Abboticin Es
  • Portugal · E.S.E. 500, Eritrocina

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/47e2933a-b34d-4c50-81b9-e1e2717927ae
GET /v1/drugs/47e2933a-b34d-4c50-81b9-e1e2717927ae?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "1",
  "form": "rakeet mikstuuraa varten",
  "route": null,
  "ddd_unit": "g",
  "strength": "40 mg/ml",
  "atc_label": "erytromysiini",
  "ma_number": "8485",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL1566",
  "authorised_at": "1983-04-20"
}
API referenceMCP serverPlans

See everything about erythromycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console